Brian Hibler is a Dermatology physician. OpenAlex indexes 65 publications with 1,900 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 Staniford St Ste 250
Boston, MA 021142517
Telephone
617-724-6960Provider last certified this registry record 7 Jul 2021.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year2025168 payments$171,210openpaymentsdata.cms.gov ↗
- Verrica Pharmaceuticals Inc.Program year20253 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
36.4%Azole Antifungal16.6%Ketoconazole100%Part D≥20 patientsLincosamide Antibacterial12.8%Clindamycin Phosphate100%Part D≥14 patients+ 1 more class in this area
Dermatology
18.7%Corticosteroid18.7%Triamcinolone Acetonide100%Part D≥33 patientsRespiratory
14.4%RNA Synthetase Inhibitor Antibacterial14.4%Mupirocin100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nonablative laser therapy for cutaneous Kaposi sarcoma: a single centre proof-of-concept study of six patients
Clinical and Experimental Dermatology
2024 - Biopsy type does not affect the number of stages during Mohs micrographic surgery: a retrospective study
Clinical and Experimental Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”